<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
______________
SCHEDULE 13G
INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
AMENDMENT NO. 2
InfoCure Corporation
------------------------------------------------------
(Name of Issuer)
Common Stock
------------------------------------------------------
(Title of Class of Securities)
456 65A 108
------------------------------------------------------
(CUSIP Number)
December 31, 1999
------------------------------------------------------
(Date of Event Which Requires Filing of the Statement)
<PAGE>
CUSIP NO. 45665A 108 13G Page 2 of 6 Pages
----------
- ------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
James K. Price
SSN:
- ------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_]1
(b) [_]2
- ------------------------------------------------------------------------------
3 SEC USE ONLY
- ------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S. Citizen
- ------------------------------------------------------------------------------
NUMBER OF SHARES 5 SOLE VOTING POWER
BENEFICIALLY OWNED 1,239,024(1)(2)(3)
BY EACH REPORTING -----------------------------------------------------------
PERSON WTH 6 SHARED VOTING POWER
-0-
-----------------------------------------------------------
7 SOLE DISPOSITIVE POWER
1,232,574(1)(2)
-----------------------------------------------------------
8 SHARED DISPOSITIVE POWER
6,450 (1)(3)
- ------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,239,024(1)(2)(3)
- ------------------------------------------------------------------------------
-2-
<PAGE>
- ------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [_]3
- ------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
4.25%(4)
- ------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- ------------------------------------------------------------------------------
(1) Reflects a 2-for-1 stock split in the form of a stock dividend on
8/19/99.
(2) Includes 60,000 shares held in a deferred compensation trust on
behalf of Mr. Price and 225,272 shares issuable upon the exercise of
presently exercisable options.
(3) Includes 6,450 shares held by Mr. Price's brother as to which Mr.
Price maintains voting control.
(4) Percentage ownership is calculated based upon 29,132,900 shares
outstanding as of October 31, 1999, as reported in the Issuer's
quarterly report on Form 10-Q dated November 15, 1999.
-3-
<PAGE>
Item 1(a). Name of Issuer:
InfoCure Corporation
Item 1(b). Address of Issuer's Principal Executive Offices:
1765 The Exchange
Suite 500
Atlanta, Georgia 30339
Item 2(a). Name of Person Filing:
James K. Price
Item 2(b). Address of Principal Business Office or, if none, Residence:
1765 The Exchange
Suite 500
Atlanta, Georgia 30339
Item 2(c). Citizenship:
U.S. Citizen
Item 2(d). Title of Class of Securities:
Common Stock
Item 2(e). CUSIP Number:
456 65A 108
Item 3. If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b),
check whether the person filing is a:
(a) [ ] Broker or dealer registered under Section 15 of the Act,
(b) [ ] Bank as defined in Section 3(a)(6) of the Act,
(c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act,
(d) [ ] Investment Company registered under Section 8 of the Investment
Company Act,
-4-
<PAGE>
(e) [ ] Investment Adviser registered under Section 203 of the Investment
Advisers Act of 1940,
(f) [ ] Employee Benefit Plan, Pension Fund which is subject to the
provisions of the Employee Retirement Income Security Act of 1974
or Endowment Fund; see 13d-1(b)(1)(ii)(F),
(g) [ ] Parent Holding Company, in accordance with Rule 13d-1(b)(ii)(G);
see Item 7,
(f) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(H).
Item 4. Ownership.
(a) Amount Beneficially Owned: 1,239,024 (1)(2)(3)
(b) Percent of Class: 4.25% (4)
(c) Number of shares as to which such person has:
(i) Sole power to vote or to 1,239,024 (1)(2)(3)
direct the vote -------------------
(ii) Shared power to vote or -0-
to direct the vote -------------------
(iii) Sole power to dispose or 1,232,574 (1)(2)
to direct the disposition of ----------------
(iv) Shared power to dispose 6,450 (1)(3)
or to direct the disposition of ----------------
(1) Reflects a 2-for-1 stock split in the form of a stock dividend on 8/19/99.
(2) Includes 60,000 shares held in a deferred compensation trust on behalf of
Mr. Price and 225,272 shares issuable upon the exercise of presently
exercisable options.
(3) Includes 6,450 shares held by Mr. Price's brother as to which Mr. Price
maintains voting control.
(4) Percentage ownership is calculated based upon 29,132,900 shares outstanding
as of October 31, 1999, as reported in the Issuer's quarterly report on
Form 10-Q dated November 15, 1999.
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial owner of more
than five percent of the class of securities, check the following [X].
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Not Applicable
-5-
<PAGE>
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company.
Not Applicable
Item 8. Identification and Classification of Members of the Group.
Not Applicable
Item 9. Notice of Dissolution of Group.
Not Applicable
Item 10. Certification.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the ordinary course of
business and were not acquired for the purpose of and do not have the effect of
changing or influencing the control of the issuer of such securities and were
not acquired in connection with or as a participant in any transaction having
such purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 16, 2000
By: /s/ James K. Price
-----------------------------------
James K. Price
InfoCure Corporation
Executive Vice President, Secretary
-6-
